The burden of invasive pneumococcal disease and the potential for reduction by immunisation
- 6 January 2002
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 19 (2) , 85-93
- https://doi.org/10.1016/s0924-8579(01)00491-5
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Cost-Effectiveness of Pneumococcal Vaccination of Older People: A Study in 5 Western European CountriesClinical Infectious Diseases, 2000
- Colonization by Streptococcus pneumoniae in human immunodeficiency virus-infected childrenThe Pediatric Infectious Disease Journal, 2000
- Risk factors for carriage of respiratory pathogens in the nasopharynx of healthy childrenThe Pediatric Infectious Disease Journal, 1999
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyThe American Journal of Medicine, 1997
- Prevalence of Human Immunodeficiency Virus Infection, Mortality Rate, and Serogroup Distribution Among Patients with Pneumococcal Bacteremia at Denver General Hospital, 1984–1994Clinical Infectious Diseases, 1997
- Preventing pneumococcal bacteremia in patients at risk. Results of a matched case-control studyArchives of internal medicine (1960), 1995
- Antibody Class and Subclass Responses to Pneumococcal Polysaccharides following Immunization of Human Immunodeficiency Virus-Infected PatientsThe Journal of Infectious Diseases, 1995
- Invasive Pneumococcal Disease in Central AustraliaClinical Infectious Diseases, 1995
- An Epidemic of Pneumococcal Disease in an Overcrowded, Inadequately Ventilated JailNew England Journal of Medicine, 1994
- Efficacy of Pneumococcal Vaccine in High-Risk PatientsNew England Journal of Medicine, 1986